بدائل البحث:
significant event » significant effect (توسيع البحث), significant level (توسيع البحث), significant effects (توسيع البحث)
reported decrease » reported disease (توسيع البحث), reported depressive (توسيع البحث), reported case (توسيع البحث)
event decrease » cement decreases (توسيع البحث), point decrease (توسيع البحث), levels decreased (توسيع البحث)
significant event » significant effect (توسيع البحث), significant level (توسيع البحث), significant effects (توسيع البحث)
reported decrease » reported disease (توسيع البحث), reported depressive (توسيع البحث), reported case (توسيع البحث)
event decrease » cement decreases (توسيع البحث), point decrease (توسيع البحث), levels decreased (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
Characteristics of adolescents with T2D cases reporting ADRs to metformin in FAERS.
منشور في 2025الموضوعات: -
6
-
7
-
8
-
9
Signal strength of reports of finasteride administration in female at the PT level.
منشور في 2025الموضوعات: -
10
Signal strength of reports of finasteride administration in male at the PT level.
منشور في 2025الموضوعات: -
11
Signal strength of reports of finasteride administration at the PT level (age < 18).
منشور في 2025الموضوعات: -
12
Signal strength of reports of finasteride administration at the PT level (age>=65).
منشور في 2025الموضوعات: -
13
Number of adverse reaction case reports of finasteride administration at the PT level.
منشور في 2025الموضوعات: -
14
Signal strength of reports of finasteride administration at the PT level (age = 18-65).
منشور في 2025الموضوعات: -
15
-
16
Eligibility criteria.
منشور في 2024"…Data will be collected and synthesized for seven pre-specified outcomes at 6 weeks and 3 months following surgery: i) change in central retinal thickness measured by optical coherence tomography (OCT), ii) best-recorded visual acuity iii) the rate of CME measured by OCT, and fluorescein angiography (FA) iv) the rate of patients experiencing clinically significant macular edema defined as the presence of CME and pre-specified thresholds for decreased visual acuity, v) patient quality of life, vi) intraocular pressure and vii) the number of patients experiencing one or more pre-specified adverse events. …"
-
17
-
18
-
19
-
20